Skip to content
left end
left end
right end

NIHR project and programme grants

Current Grants

Here is a list of our current NIHR-funded research grants. Please click on the links in the table below to view the grant summary, or view completed grants.

Grant reference

Chief Investigator


Title and link to grant details

Dates and original duration ("+" indicates extension)

Total Awarded


Wren, Dr Yvonne

NIHR Programme Grant for Applied Research (PGfAR)

Improving outcomes by addressing variation in unmet needs at transition to adult care for young people born with cleft lip and palate (Cleft@20)

01/04/2024 - 31/03/2029 (60 months)



Horwood, Dr Jeremy

NIHR Public Health Research (PHR)

Evaluating the implementation of Common Ambition Bristol to reduce HIV inequities in African and Caribbean heritage communities

01/02/2024 - 30/09/2025 (20 months)



Birchenall, Dr Katherine

NIHR Efficacy and Mechanism Evaluation (EME)

PravastatIn tO preveNt prEtErm biRth (PIONEER): a parallel group randomised placebo-controlled trial

01/08/2023 - 31/07/2028 (60 months)



Atan, Dr Denize

NIHR Programme Development Grant (PDG)

Improving the DIagnostic accuracy of referrals for Papilloedema (DiPP) from primary to secondary care: the development of clinical guidelines and educational materials

01/05/2023 - 31/08/2024 (16 months)



Gibbison, Dr Ben

NIHR Programme Development Grant (PDG)

OPTIC: OPTimising the prevention, identification and management of ICU-Delirium

01/05/2023- 31/10/2024 (18 months)



Avery, Dr Kerry

NIHR Research for Patient Benefit (RfPB)

Impact of feedback from Real-time, electronic symptom monitoring on post-discharge recOvery after Surgery for oEsophago-gastric cancer: a multi-centre randomised controlled trial (the ROSE study)

01/12/2022 -30/11/2025 (36 months)



West, Nicola

NIHR Research for Patient Benefit (RfPB)

Feasibility study: To assess whether reducing periodontal infection (gum disease) slows the progression of cognitive impairment associated with Alzheimer's disease (MySmile).

01/07/2022 - 30/06/2025 (36 months)



Pryce, Dr Helen

NIHR Health Services and Delivery Research (HS&DR)

Hearing Loss and Patient Reported Experience (HELP): Using patient experience to improve audiology services

01/05/2022 -30/04/2025 (36 months)



Benger, Professor Jonathan

NIHR Health Technology Assessment (HTA)

Randomised trial of the clinical and cost effectiveness of a supraglottic airway device versus tracheal intubation during in-hospital cardiac arrest (AIRWAYS-3).

01/01/2022 -31/12/2025 (48 months)



Lyttle,  Mark

NIHR Policy Research Programme (PRP)

To evaluate the use of the ICON programme in its purpose to prevent instances of abusive head trauma (AHT) in infants

01/05/2021 -28/02/2023 (22 months)



Lazarus, Dr Rajeka

NIHR Policy Research Programme (PRP)

A single-blind, phase IV UK multi-centre randomised controlled trial to determine reactogenicity and immunogenicity of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCov)

01/04/2021 -31/03/2025 (19 months + 30 months)

£1,778,901 + £93,967 + £1,147,641

= £3,020,509


Bourdeaux, Dr Chris

NIHR Invention for Innovation (i4i)

SMARTT Critical Care Pathways - (Safe, Machine Assisted, Real Time Transfer) An artificial intelligence based decision support tool to enable safer and more timely critical care transfer

01/01/2021 - 31/12/2023 (36 months)



Dick, Professor Andrew

NIHR Health Technology Assessment (HTA)

Adalimumab vs placebo as add-on to Standard Therapy for autoimmune Uveitis: Tolerability, Effectiveness and cost-effectiveness. The ASTUTE pragmatic randomized controlled trial.

01/04/2020 - 31/03/2024 (48 months)



Gibbison, Dr Ben

NIHR Efficacy and Mechanism Evaluation (EME)

Carbon Dioxide Insufflation and Brain Protection During Open Heart Surgery. A Randomized Controlled Trial. CO-Two trial

01/10/2019 - 31/10/2025 (41 months + 33 months)

£1,286,276 + £228,710



Pufulete, Dr Maria

NIHR Health Technology Assessment (HTA)

Effectiveness and cost-effectiveness of inspiratory muscle training (IMT) for reducing postoperative pulmonary complications (PPC): a sham-controlled randomised controlled trial (RCT) (INSPIRE)

01/10/2018-31/07/2023 (42 months + 16 months)